Smaller cardiac cell size and reduced extra-cellular collagen might be beneficial for hearts of Ames dwarf mice

International Journal of Biological Sciences

Volumn 6, Issue 5, 2010, Pages 475-490

  Helms, Scott A ^a   Azhar, Gohar ^a   Zuo, Chunlai ^a,c   Theus, Sue A ^c   Bartke, Andrzej ^b   Wei, Jeanne Y ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Ames dwarf; Collagen; Hypertrophy

Indexed keywords

MUS;

EID: 77956946043     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.6.475     Document Type: Article

References (87)

1. Hsiang-Ching K, Hoyert DL, et al. Deaths: Final Data for 2005. National Vital Statistics Reports 2008; 56(10):5.
2. Wei JY. Age and the cardiovascular system. N Engl J Med 1992; 327:1735-1739.
3. Pugh KG, Wei JY. Clinical Implications of Physiological Changes in the Aging Heart. Drugs & Aging 2001; 18: 263-276.
4. Wei JY. Understanding the Aging Cardiovascular System. Geriatrics and Gerontology International 2004; 4: S298-S303.
5. Wu W, Cogan JD, et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nature Genetics 1998;18(2):147-149.
6. White HK, Petrie C, et al. Effects of an Oral Growth Hormone Secretagogue Capromorelin in Older Adults. JCEM 2009; 94(4):1198-206.
7. Sjögren K, Liu JL, et al. (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 1999; 96(12):7088-92.
8. Masternak MM, Panici JA, et al. The effects of growth hormone (GH) treatment on GH and insulin/IGF-1 signaling in long-lived Ames dwarf mice. J Gerontol A Biol Sci Med Sci. 2010; 65(1):24-30.
9. Egecioglu E, Andersson IJ, et al. Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function. Am J Physiol Endocrinol Metab. 2007; 292(5):E1418-25.
10. Koedam JA, Hoogerbrugge CM, et al. Insulin-like growth factor-binding protein-3 protease activity in Snell normal and Pit-1 deficient dwarf mice. J Endocrinol.1998; 157(2):295-303.
11. Bartke A. Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings. Aging Cell 2008;7(3):285-90.
12. Coschigano KT, Holland AN, et al. Flyvbjergs, insulin, and insulin A, Kopchick JJ Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 2003; 144: 3799-3810.
13. Rutishauser J, Schmid C, et al. Growth hormone, but not insulin-like growth factor I, induces a serum protease activity for insulin-like growth factor binding protein-3 in hypophysectomized rats in vivo. FEBS Lett. 1993; 334(1):23-6.
14. Koedam JA, Hoogerbrugge CM, et al. Insulin-like growth factor-binding protein-3 protease activity in Snell normal and Pit-1 deficient dwarf mice. J Endocrinol. 1998; 157(2):295-303.
15. Jiang M, Xu A, et al. Thyroid hormone downregulates the expression and function of sarcoplasmic reticulum-associated CaM kinase II in the rabbit heart. Am J Physiol Heart Circ Physiol. 2006; 291(3):H1384-94.
16. Kenessey A, Ojamaa K. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem. 2006; 281(30):20666-72.
17. Stǎnescu C, Branidou K, et al. Heart failure and dilated cardiomyopathy associated with severe longstanding untreated hypothyroidism. Rom J Intern Med. 2007; 45(1):77-83.
18. Rouf R, Greytak S, et al. Increased FOG-2 in failing myocardium disrupts thyroid hormone-dependent SERCA2 gene transcription. Circ Res. 2008;103(5):493-501.
19. Kelly PA, Binart N, et al. Prolactin receptor signal transduction pathways and actions determined in prolactin receptor knockout mice. Biochem Soc Trans. 2001; 29(Pt 2):48-52
20. Goffin V, Binart N, et al. Prolactin: the new biology of an old hormone. Annu Rev Physiol. 2002; 64:47-67.
21. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 2001; 23:291-299.
22. Wei JY, Spurgeon HA, Lakatta EG. Excitation-contraction in rat myocardium: alterations with adult aging. Am J Physiol. 1984 Jun;246(6 Pt 2):H784-91.
23. Yin FC, Spurgeon HA, Rakusan K, Weisfeldt ML, Lakatta EG. Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am J Physiol. 1982 Dec;243(6):H941-7
24. Bokov AF, Lindsey ML, et al. Long-lived Ames dwarf mice are resistant to chemical stressors. J Gerontol A Biol Sci Med Sci. 2009; 64(8):819-27.
25. Gurkan UA, Gargac J, et al. The Sequential Production Profiles of Growth Factors and Their Relations to Bone Volume in Ossifying Bone Marrow Explants. Tissue Eng Part A. 2010. [Epub ahead of print]
26. Rochira V, Zirilli L, et al. Tall Stature without Growth Hormone: Four Male Patients with Aromatase Deficiency. J Clin Endocrinol Metab. 2010. [Epub ahead of print]
27. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003; 423:332-336.
28. Berryman DE, List EO, et al. Two-year body composition analyses of long-lived GHR null mice. J Gerontol A Biol Sci Med Sci. 2010; 65(1):31-40.
29. Horwich TB, Fonarow GC. Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure. J Am Coll Cardiol. 2010; 55(4):283-93.
30. Badheka AO, Rathod A, Kizilbash MA. et al. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med. 2010; 123(7):646-51.
31. Oreopoulos A, Kalantar-Zadeh K, et al. The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med. 2009; 25(4):643-59
32. Ren J, Brown-Borg HM. Impaired cardiac excitation-contraction coupling in ventricular myocytes from Ames dwarf mice with IGF-1 deficiency. Growth Hormone and IGF Research 2002; 12: 99-105.
33. Cittadini A, Strömer H, et al. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation. 1996; 93(4):800-9.
34. Cittadini A, Strömer H, et al. Consequences of growth hormone deficiency on cardiac structure, function, and beta-adrenergic pathway: studies in mutant dwarf rats. Endocrinology. 1997; 138(12):5161-9
35. Palmen M, Daemen MJAP, et al. Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice. Cardiovascular Research 2001; 50: 516-524
36. Aagaard P, Suetta C et al. Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure. Scand J Med Sci Sports 2010; 20(1): 49-64.
37. Frontera WR, Hughes VA, et al. Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol. 2000; 88(4): 1321-6.
38. Gerdes AM, Liu Z, et al. Changes in nuclear size of cardiac myocytes during the development and progression of hypertrophy in rats. Cardioscience 1994; 5(3):203-8.
39. McMullen JR, Sherwood MC, et al. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation. 2004; 109(24):3050-5.
40. Sadoshima J, Izumo S. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ Res. 1995; 77(6):1040-52.
41. Feng Z, Hu W, et al. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 2007; 67(7):3043-53.
42. Hayashi AA, Proud CG. The rapid activation of protein synthesis by growth hormone requires signaling through mTOR. Am J Physiol Endocrinol Metab. 2007; 292(6):E1647-55.
43. Boluyt MO, Zheng JS, et al. Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase. Circ Res. 1997; 81(2):176-86.
44. Koda M, Takemura G, et al. Nuclear hypertrophy reflects increased biosynthetic activities in myocytes of human hypertrophic hearts. Circ J. 2006; 70(6):710-8.
45. Lombardi G, Galdiero M, et al. Acromegaly and the cardiovascular system. Neuroendocrinology. 2006;83(3-4):211-7.
46. Isoyama S, Grossman W, et al. Effect of age on myocardial adaptation to volume overload in the rat. J Clin Invest 1988; 81:1850-1857.
47. Isoyama S, Wei JY, et al. Effect of age on the development of cardiac hypertrophy produced by aortic constriction in the rat. Circ Res 1987; 61:337-345.
48. Isoyama S, Grossman W, et al. Effect of age on myocardial adaptation to volume overload in the rat. J Clin Invest 1988; 81:1850-1857.
49. Lipsitz LA, Jonsson PV, et al. Reduced supine cardiac volumes and diastolic filling rates in elderly patients with chronic medical conditions. JAGS 1990; 38: 103-7.
50. Zhang X, Azhar G, et al. Model of functional cardiac aging: young adult mice with mild overexpression of serum response factor. Am J Physiol Regul Integr Comp Physiol. 2003; 285(3):R552-60.
51. Bokov AF, Lindsey ML, et al. Long-lived ames dwarf mice are resistant to chemical stressors. Gerontol A Biol Sci Med Sci. 2009; 64(8):819-27.
52. Reddy AK, Amador-Noguez D, et al. Cardiac function in young and old Little mice. J Gerontol A Biol Sci Med Sci. 2007; 62(12):1319-25.
53. Ren J, Brown-Borg HM. Impaired cardiac excitation-contraction coupling in ventricular myocytes from Ames dwarf mice with IGF-I deficiency. Growth Horm IGF Res. 2002; 12(2):99-105.
54. Palmen M, Daemen MJ, et al. Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice. Cardiovasc Res. 2001; 50(3):516-24.
55. Janicki JS, Brower GL. The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail. 2002; 8(6 Suppl):S319-25.
56. Díez J. Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease. Circ J. 2008; 72 (Suppl A):A8-12.
57. Brower GL, Gardner JD, et al. The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg. 2006; 30(4):604-10.
58. López Salazar B, Ravassa Albéniz S, et al. Altered fibrillar collagen metabolism in hypertensive heart failure. Current understanding and future prospects Rev Esp Cardiol. 2006; 59(10):1047-57
59. Mak GJ, Ledwidge MT, et al. Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone. J Am Coll Cardiol. 2009; 54(18):1674-82.
60. Baicu CF, Stroud JD, et al. Changes in extracellular collagen matrix alter myocardial systolic performance. Am J Physiol Heart Circ Physiol. 2003; 284(1):H122-32.
61. Cox MA, Kortsmit J, et al. Tissue-Engineered Heart Valves Develop Native-Like Collagen Fiber Architecture. Tissue Eng Part A. 2010 May;16(5):1527-37
62. Flurkey K, Papaconstantinou J, et al. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A. 2001; 98(12):6736-41
63. Fujimoto E, Kobayashi T, et al. AGE-modified collagens I and III induce keratinocyte terminal differentiation through AGE receptor CD36: epidermal-dermal interaction in acquired perforating dermatosis. J Invest Dermatol. 2010; 130(2):405-14.
64. Brüel A, Oxlund H. The effect of growth hormone on rat myocardial collagen. Growth Horm IGF Res. 1999; 9(2):123-30.
65. Brüel A, Oxlund H. The effect of growth hormone on rat myocardial collagen. Growth Horm IGF Res.1999; 9(2):123-30.
66. Drobnik J, Ciosek J et al. Experimental hypothyroidism increases content of collagen and glycosaminoglycans in the heart. J Physiol Pharmacol. 2009; 60(3):57-62.
67. Simonsick EM, Newman AB, et al. Health ABC Study Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med. 2009; 169(21):2011-7.
68. Wei JY, Genecin A, et al. Coronary spasm with ventricular fibrillation during thyrotoxicosis: response to attaining euthyroid state. Am J Cardiol 1979; 43:335-339.
69. Yao J, Eghbali M. Decreased collagen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy. Response of cardiac fibroblasts to thyroid hormone in vitro. Circ Res. 1992; 71(4):831-9.
70. Ghose Roy S, Mishra S, et al. Thyroid hormone induces myocardial matrix degradation by activating matrix metalloproteinase-1. Matrix Biol. 2007; 26(4):269-79.
71. Zhou B, Ma Q, et al. Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart. J Clin Invest. 2009; 119(6):1462-76.
72. Louis A, Bartke A, et al. Effects of Growth Hormone and Thyroxine Replacement Therapy on Insulin Signaling in Ames Dwarf Mice. J Gerontol A Biol Sci Med Sci. 2010. [Epub ahead of print]
73. Csiszar A, Labinskyy N, et al. Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. Am J Physiol Heart Circ Physiol. 2008; 295(5):H1882-94.
74. Lembo G, Rockman H, et al. Elevated Blood Pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. J Clinical Invest. 1996; 98(11): 2648-2655.
75. Sun LY, Al-Regaiey K, et al. Local expression of GH and IGF-I in the hippocampus of GH-deficient long-lived mice. Neurobiol Aging 2005; 26: 929-937.
76. Masternak MM, Al-Regaiey KA, et al. Caloric restriction and growth hormone receptor knockout: effects on expression of genes involved in insulin action in the heart. Exp Gerontol 2006; 41: 417-429.
77. Stein M, Boulaksil M, et al. Reduction of fibrosis related arrthythmias by chronic renin-angiotensin-aldosterone-system inhibitors in an aged mouse model. AJP 2010; in press.
78. Akar FG, Spargg DD, et al. Mechanisms of underlying conduction slowing and arrhythmogenesis in non-ischemic dilated cardiomyopathy. Circ Res 2004; 95: 717-725.
79. Stein M, Noorman M, et al. Dominant arrhythmia vulnerability of the right ventricle in senescent mice. Heart Rhythm 2008; 5: 438-448.
80. Li and Ren. Influence of cardiac-specific over-expression of insulin-like growth factor on life-span and aging associated changes in cardiac intracellular Ca+ homeostasis, protein damage and apoptotic protein expression. Aging Cell 2007,6:799-806.
81. Barzilai N, Bartke A. Biological approaches to mechanistically understand the healthy life span extension achieved by calorie restriction and modulation of hormones. J Gerontol A Biol Sci Med Sci. 2009; 64(2):187-91.
82. Schriner SE, Linford NJ, et al. Extension of murine lifespan by overexpression of catalase targeted to mitochondria. Science 2005; 208:1909-1911.
83. Mitsui A, Hamuro J et al. Overexpression of human of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal. 2002; 4(4):693-6.
84. Dhahbi JM, Tsuchiya T, et al. Gene expression and physiologic responses of the heart to the initiation and withdrawal of caloric restriction. J Gerontol A Biol Sci Med Sci. 2006 Mar;61(3):218-31
85. References and further reading may be available for this article. To view references and further reading you must purchase Swindell WR. Genes regulated by caloric restriction have unique roles within transcriptional networks. Mechanisms of Ageing and Development 2008;129: 580-592
86. Anand K, Mooss AN, et al. Aldosterone inhibition reduces the risk of sudden cardiac death in patients with heart failure. Renin Angiotensin Aldosterone Syst. 2006; 7(1):15-9.
87. Werner C, Pöss J, et al. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy? Drugs 2010; 70(10):1215-30